Cancerfromwww.dw.com2 days agoMerck's Keytruda: A lifesaving drug, a global divideKeytruda's success highlights disparities in global access to cancer treatment due to pricing, patents, and regulatory systems.
Healthcarefrom24/7 Wall St.2 months agoMerck Reports Earnings Tuesday Morning After Gaining 13% Over the Past YearMerck reports Q4 2025 earnings Feb. 3 before market; Street expects $2.01 EPS on $16.12B revenue; Keytruda, Gardasil, guidance and Verona integration are focus.